0121-4803 : Pink Bismuth 262 mg/15ml Oral Suspension

Labeler: Pharmaceutical Associates, Inc.
Product Type: Human OTC Drug
Drug Name:  Pink Bismuth
Dosage Form: Oral Suspension
Application #: part335
Rev. Date: 

NDC Package Codes:

  • 0121-4803-30: 4 TRAY IN 1 CASE (0121‑4803‑30) > 10 CUP, UNIT‑DOSE IN 1 TRAY > 30 ML IN 1 CUP, UNIT‑DOSE

Active Ingredients:

  • Bismuth Subsalicylate

Dosage Strength:

  • 262 mg/15mL

Related Products:

Based on records with the same trade name.
  • 0536-1810 Pink Bismuth 262 mg/15ml Oral Liquid by Rugby Laboratories, Inc.
  • 0603-0235 Bismuth Subsalicylate 262 mg Chewable Tablet by Qualitest Pharmaceuticals
  • 53041-527 Pink-bismuth 262 mg/15ml Oral Liquid by Guardian Drug Company
  • 57896-392 Pink Bismuth 262 mg/15ml Oral Liquid by Geri-care Pharmaceuticals, Corp
  • 67510-0505 Pink Bismuth 262 mg/15ml Oral Liquid by Kareway Product, Inc.
  • 68788-0190 Bismuth Subsalicylate 262 mg Chewable Tablet by Preferred Pharmaceuticals, Inc
  • 70005-047 Pink Bismuth 262 mg/15ml Oral Liquid by We Care Distributor Inc.


Scan the QR code below to easily reference this data in the future:

NDC 0121-4803 QR Code

< Prev: 0121-4802Next: 0121-4809 >

Related Discussions:

composition of bismuth subsalicylate drug
This is a drug which is used for diarrhea,a antidiarrheal drug...

Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 July 2015.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA